Miao Wang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- RNA modifications and cancer 12
- Metabolomics and Mass Spectrometry Studies 11
- Circular RNAs in diseases 9
-
- Cancer-related molecular mechanisms research 19
- MicroRNA in disease regulation 15
- Cancer, Hypoxia, and Metabolism 10
- Co-authors
- Garret A. FitzGerald (18 shared papers)Xianlin Han (21 shared papers)Ying Yu (2 shared papers)Tilo Großer (2 shared papers)Emer M. Smyth (1 shared paper)Ellen Puré (4 shared papers)John A. Lawson (7 shared papers)Zhixing Cao (6 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (6 papers)Oncotarget (5 papers)Circulation (5 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Frontiers in Cardiovascular Medicine (4 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Miao Wang
384 papers receiving 10.6k citations
Miao Wang's Hit Papers
Peers
Comparison fields: 5 of 193
- Cancer Research 1.2k
- Biochemistry 590
- Pharmacology 1.1k
- Molecular Biology 3.8k
- Biomaterials 691
Countries citing papers authored by Miao Wang
This map shows the geographic impact of Miao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miao Wang more than expected).
Fields of papers citing papers by Miao Wang
This network shows the impact of papers produced by Miao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miao Wang. The network helps show where Miao Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Miao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 406 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 437 | |
| 2 | Myricetin: A review of the most recent research Hit paper breakdown → | 2020 | 288 |
| 3 | 2013 | 251 | |
| 4 | 2015 | 224 | |
| 5 | 2014 | 223 | |
| 6 | 2012 | 177 | |
| 7 | 2006 | 175 | |
| 8 | 2005 | 172 | |
| 9 | 2007 | 155 | |
| 10 | 2019 | 147 | |
| 11 | 2010 | 137 | |
| 12 | 2020 | 130 | |
| 13 | 2004 | 129 | |
| 14 | 2018 | 129 | |
| 15 | 2008 | 119 | |
| 16 | 2015 | 112 | |
| 17 | 2015 | 108 | |
| 18 | 2020 | 107 | |
| 19 | 2015 | 104 | |
| 20 | 2013 | 103 |
About Miao Wang
Miao Wang is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Pharmacology, having authored 406 papers that have together received 10.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (19 papers), MicroRNA in disease regulation (15 papers), Inflammatory mediators and NSAID effects (14 papers), RNA modifications and cancer (12 papers), Metabolomics and Mass Spectrometry Studies (11 papers), Adipose Tissue and Metabolism (10 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Circular RNAs in diseases (9 papers). The work is most often cited by research in Cancer Research (1.2k citations), Biochemistry (590 citations), Pharmacology (1.1k citations), Molecular Biology (3.8k citations) and Biomaterials (691 citations). Miao Wang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Garret A. FitzGerald, Xianlin Han, Ying Yu, Tilo Großer, Emer M. Smyth, Ellen Puré, John A. Lawson, Zhixing Cao, Rowland H. Han and Chuanjie Guo. Their work appears in journals such as Biochemical and Biophysical Research Communications, Oncotarget, Circulation, Arteriosclerosis Thrombosis and Vascular Biology and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.